Cancer research investment boost

July 18, 2016

The Cancer Therapeutics Cooperative Research Centre’s partners are reinvesting funds back into cancer research.

funding cancer research

Featured image above: Cancer research at the Cancer Therapeutics Cooperative Research Centre has received a funding boost. Credit: CTx

The Chief Executive of the Cancer Therapeutics Cooperative Research Centre (CTx), Dr Warwick Tong, announced last week that a majority of its current partners have chosen to reinvest their share of the recent cash distribution from CTx back into the organisation.

In January 2016 CTx licensed its PRMT5 Project to MSD (known as Merck in the US and Canada) in a landmark deal and received over $14 million dollars as its share of the signature payment. Novel drugs arising from the project will be developed and commercialised by Merck. Potential future milestone payments and royalties will also be shared within the partnership.

“Our 2013 application to the Department of Industry CRC Programme outlined the intent to actively secure reinvestment of funds from any commercialisation success back into our cancer drug development activities”, said Tong. “To have this commitment from our partners is the validation and support we wanted.

“The more than seven million dollars will boost our ability to deliver new cancer drugs for adults and children”.

“CTx has made great use of its partnership network to deliver this project,” said Professor Grant McArthur Chair of the CTx Scientific Advisory Board. “The reinvestment is a very positive recognition by the partners that CTx will continue to provide benefits for patients and strengthen translational cancer research in Australia”.

This article was first published by the Cancer Therapeutics Cooperative Research Centre on 29 June 2016. Read the original article here.

To read more articles on research funding, visit:

$22.6 million research funding – A round of applications is expected to open in August for 11 newly funded Cooperative Research Centre (CRC) projects.

Australian research funding infographic – The latest OECD figures reveal how Australia’s science and research funding compares with other countries.

Related stories

One thought on “Eye for detail”

  1. Completely normal to have an avatar as a life partner, especially for the oldies as at 120 they’ll be too drugged up and dementia’d out to notice any occasional repetitive flutters due to variability in power supply from solar stations – that allows for more basic experiences in the real world , capturing the best of the ancient spirit of the sodomites city! No more troubles and the only role for AI robotic police, the only moving parts, is to stop and eliminate those rebelling from the virtual world using their bodies as food in an internet online enabled Soylent Green Restaurant services for the elderly!

Leave a Reply

Your email address will not be published. Required fields are marked *